• Clinical manifestations and diagnostic approaches to the histamine intolerance syndrome in children

Clinical manifestations and diagnostic approaches to the histamine intolerance syndrome in children

SOVREMENNAYA PEDIATRIYA.2017.1(81):104-109; doi 10.15574/SP.2017.81.104

Marushko Y. V., Moskovenko E. D.
Bogomolets National Medical University, Kyiv, Ukraine

The aim of this work is to summarize the literature data and personal observations concerning the peculiarities and dagnostika syndrome of intolerance to histamine( HIT) in children. We examined 28 children with clinical proyavlenie HIT aged between 3 to 12 years. The average age amounted to 5 years and 9 months. The diagnosis of HIT in these patients was confirmed to provedennom skin prick test with 1% histamine. For children with the HIT to symptomatic treatment added the individually developed dietary recommendations with the exception of products, rich on histamine. Use in complex treatment of children with symptoms of HIT elimination diet showed a decrease of clinical manifestations of HIT at different stages of treatment.

Key words: syndrome of intolerance to histamine, children, diagnostics, diet therapy.

References

1. Naumova OA. 2014. Diagnosticheskoe znachenie opredeleniya urovnya diaminoksidazyi u patsientov s sezonnyim allergicheskim rinitom i perekpestnoy pischevoy allergiey. RinologIya. 3: 57—66.

2. Makarova SG, Borovik TE, Guseva IM, Yatsyik GV. 2006. Profilaktika pischevoy allergii v rannem detskom vozdaste. Voprosyi sovr pediatrii. 4: 69—74.

3. Puhlik BM. 2011. Allergiya — problema ne tolko allergologov. Zaporozhskiy med zhurn. 13; 2: 108—110.

4. Rukovodstvo po immunofarmakologii. 1998. Pod red MM Deyla, DzhK Formena. Moskva, Meditsina: 332.

5. Antonio Rosell Camps Aspectos clinicos Y Nutricionales De La Intolerancia A La Histamina En Pacientes Pediatricos con Sintomatologia Digestiva Cronica. 2015. Programa de doctorado de Ciencias Medicas Basicas: 131.

6. Bach JF. 2002. The effect of infections on susceptibility to autoimmune and allergic disease. N Engl J Med. 347: 911—920. https://doi.org/10.1056/NEJMra020100; PMid:12239261

7. Bieganski T. 1983. Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. Acta Physiolo Pol. 34: 139—54. PMid:6416024

8. Chiriac AM, Demoly P. 2013. Respiratory allergies. Presse Med. 42; 4 Pt 1: 395—404. https://doi.org/10.1016/j.lpm.2012.06.005; PMid:22884514

9. Shahsadi N, Rani Z, Asad F, Hussain I. 2015. Chronic urticaria: An approach towards etiology and diagnosis. Part 1. Journal of Pakistan Association of Dermatologists. 25(4): 303—313.

10. Verma A, Deb DK, Sassano A et al. 2002. Cutting edge: activation of the p38 mitogen activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia. J Immunol. 168: 5984—8. https://doi.org/10.4049/jimmunol.168.12.5984; PMid:12055203

11. Kofler H, Aberrer W, Deibi M et al. 2009. Diamine oxidase (DAO) serum activity: not a useful marker for diagnosis of histamine intolerance. Allergologie. 32: 105—9. https://doi.org/10.5414/ALP32105

12. Colome Rivero G, Tormo Carnicer R, Rosell Camps A et al. 2014. Diaminooxidase low levels and paediatric gastrointestinal pathology. 47 th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. 9—12 June 2014, Jerusalem, Israel.

13. Sattler, Hafner D, Klotter HJ et al. 1988. Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DO). Agents and Actions. 23; 3—4: 361—365.

14. Rosell-Camps A, Zibetti S, Perez-Esteban G et al. 2013. Histamine intolerance as a cause of chronic digestive complaints in pediatric patients. Revesp Enferrm Dig (Madrid). 105; 4: 201—207. https://doi.org/10.4321/S1130-01082013000400004

15. Jarisch R, Gоtz M, Hemmer W et al. 2004. Histamin-Intoleranz. Histamin und Seekrankheit. 2 ed. Stuttgart, NewYork, Georg Thieme Verlag.

16. Jadidi-Niaragh F, Mirshafiey A. 2010. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology. 59: 180—9. https://doi.org/10.1016/j.neuropharm.2010.05.005; PMid:20493888

17. Laura Maintz, Thomas Bieber, Natalija Novak. Histamine Intolerance in Clinical Practice.

18. Kofler L, Ulmer H, Kofler H. 2011. Histamine 50-Skin-Prick Test: A Tool to Diagnose Histamine Intolerance. International Scholarly Research Network ISRN AllergyVolume 2011, Article ID 353045, 5 pages https://doi.org/10.5402/2011/353045

19. Maintz L, Novac N. 2007. Histamine and histamine intolerance. Am J Clin Nutr. 85: 1185—96. PMid:17490952

20. Maintz L, Bieber T, Novak N. 2006. Histamine intolerance in clinical practice. Dtsch Arttebl. 103(51—52): 3477—83.

21. Rueff F, Przybilla B. 2004. Hauttests zur Diagnose von Soforttyp-Allergien. Erschienen. Manuale allergologicum. G Schultz-Werninghaus, Th Fuchs, C Bachert, U Wahn, Eds. Dustri, Munchen, Germany: 491—511.

22. Schwelberger HG. 2009. Histamine intolerance: overestimated or underestimated? Inflamm Res. 58(S1): 51—2. https://doi.org/10.1007/s00011-009-2004-4; PMid:19271146

23. Music E, Korosec P, Silar M et al. 2013. Serum diamine oxidasa activity as a diagnostic test for histamine intolerance. Wien Kin Wochenschr. 125(9—10): 239—43. https://doi.org/10.1007/s00508-013-0354-y; PMid:23579881

24. Steinbrecher I, Jarisch R. 2005. Histamin und Kopfschmerz. Allergologie. 28: 84—91. https://doi.org/10.5414/ALP28085

25. Izquierdo J, Mon D, Lorente M, Soler Singla L. 2013. Un estudio randomizado doble ciego para el tratamiento con Diaminooxidasa (DAO) en pacientes con migrana y deficit de actividad DAO. XXI World Congress of neurology. Viena, Austria.

26. Wantke F, Gotz M, Jarisch R. 1993. Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy. 23: 982—5. https://doi.org/10.1111/j.1365-2222.1993.tb00287.x; PMid:10779289

Содержание журнала Full text of article